The TB Test Maker Going Private for €10.8bn, Plus a GPS Rival | Tech Arcade Podcast

Oct 24, 2026 · News · Startups & funding

Private equity firm EQT has agreed to take Qiagen, maker of the QuantiFERON tuberculosis blood test, private in a deal worth about €10.8 billion, and we explain why the premium looks thin or generous depending on when you start counting. Then, Xona Space Systems has raised $250 million to build Pulsar, a low Earth orbit navigation network that it claims will be far stronger and more precise than GPS.

Full story: https://www.techarcade.io/the-firm-behind-the-world-s-go-to-tb-blood-test-just-agreed-to-a-10-8-billion-cash-buyout/

Full story: https://www.techarcade.io/six-satellites-250-million-and-a-real-shot-at-dethroning-gps/

Sources

https://www.biospace.com/press-releases/qiagen-and-eqt-private-equity-announce-agreement-on-a-recommended-voluntary-all-cash-public-takeover-offer

https://businesswire.com/news/home/20220323005949/en/QIAGEN-Reaches-Milestone-With-100-Million-QuantiFERON-Tests-Used-to-Detect-TB

https://www.genengnews.com/topics/bioprocessing/eqt-to-acquire-qiagen-for-12-1b-plans-to-take-tools-diagnostics-provider-private/

https://www.raptorgroup.com/news/xona-what-comes-after-gps-our-250m-series-d

https://www.satellitetoday.com/technology/2026/10/23/xona-prepares-to-start-navigation-service-in-beta-with-recent-launch-and-250m-raise/

https://payloadspace.com/xona-raises-250m-series-d-to-scale-commercial-gps-constellation/

https://gps.gov/systems/gps/space

Where sources differ: Xona's own post says customer service begins in 2027, while Via Satellite reports beta service from early 2027.

More at https://www.techarcade.io

#techarcade #qiagen #privateequity #gps #spacetech

Watch on YouTube ↗Subscribe

▶ More videos

Video library →